Heregulin-β is especially potent in activating phosphatidylinositol 3- kinase in nontransformed human mammary epithelial cells

Journal of Cellular Physiology

Volumn 183, Issue 3, 2000, Pages 301-313

  Ram, Tracy G ^a   Hosick, Howard L ^a   Ethier, Stephen P ^b  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; INSULIN; NEU DIFFERENTIATION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P85; WORTMANNIN;

ARTICLE; BREAST EPITHELIUM; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MITOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; BREAST; BREAST NEOPLASMS; CELL DIVISION; CELL LINE; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; FEMALE; HUMANS; INSULIN; NEUREGULIN-1; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; TUMOR CELLS, CULTURED;

EID: 0034091963     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(200006)183:3<301::AID-JCP2>3.0.CO;2-W     Document Type: Article

References (68)

1. Aaronson SA. 1991. Growth factors and cancer. Science 254:1146-1153.
2. Alimandi M, Romano A, Curia MC, Muraro K, Fedi P, Aaronson SA, Di Fiore PP, Kraus MH. 1995. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. Oncogene 10:1813-1821.
3. Auger KR, Serunian LA, Soltoff SP, Libby P, Cantley LC. 1989. PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells. Cell 57:167-175.
4. Backer J, Myers MG, Shoelson SE, Chin DJ, Sun X-J, Miralpeix M, Hu P, Margolis B, Skolnik EY, Schlessinger J, White MF. 1992. Phosphatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J 11:3469-3479.
5. Band V, Sager R. 1991. Tumor progression in breast cancer. In: Rhim JS, Dritschilo J, editors. Neoplastic transformation in human cell culture. Totowa, NJ: The Humana Press. p 169-178.
6. Band V, Zajchowski D, Swisshelm K, Trask D, Kulesa V, Cohen C, Connally J, Sager R. 1990. Tumor progression in four mammary epithelial cell lines derived from the same patient. Cancer Res 50:7351-7357.
7. Carpenter CL, Auger KR, Duckworth BC, Hou W-M, Schaffhausen B, Cantley LC. 1993. A tightly associated serine/threonine protein kinase regulates phosphoinositide 3-kinase activity. Mol Cell Biol 13:1657-1665.
8. Carraway KL, Cantley LC. 1994. A neu acquaintance of erbB3 and erbB4: a role for receptor heterodimerization in growth signaling. Cell 78:5-8.
9. Carraway KL, Sliwkowski MX, Akita R, Platko JV, Guy PM, Nuijens A, Diamonti AJ, Vandlen RL, Cantley LC. 1994. The erbB3 gene product is a receptor for heregulin. J Biol Chem 269:14303-14306.
10. Cheatham B, Vlahos CJ, Cheatham L, Wang L, Blenis J, Kahn CR. 1994. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol 14:4902-4911.
11. S6k activation mediated by phosphatidylinositol-3-OH kinase. Nature 370:71-75.
12. c-src: a possible phosphatidylinositol kinase. Cell 50:1031-1037.
13. Coussens L, Yang-Feng TL, Liao Y-C, Chen E, Gray A, McGrath J, Seeburg PH, Liberman TA, Schlessinger J, Francke U, Levinson A, Ullrich A. 1985. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230:1132-1139.
14. Di Fiore PP, Segatto O, Lonardo F, Faziolo F, Pierce JH, Aaronson SA. 1990. The carboxy-terminal domains of erbB-2 and epidermal growth factor receptor exert different regulatory effects on intrinsic receptor tyrosine kinase function and transforming activity. Mol Cell Biol 10:2749-2756.
15. Escobedo JA, Kaplan DR, Kavanaugh M, Turck CW, Williams LT. 1991a. A phosphatidylinositol-3 kinase binds to platelet-derived growth factor receptors through a specific receptor sequence containing phosphotyrosine. Mol Cell Biol 11:1125-1132.
16. Escobedo JA, Navankasattusas S, Kavanaugh WM, Milfay D, Fried VA, Williams LT. 1991b. cDNA cloning of a novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF β-receptor. Cell 65:75-82.
17. Ethier SP, Summerfelt RM, Cundiff KC, Asch BB. 1990. The influence of growth factors on the proliferative potential of normal and primary breast cancer-derived human breast epithelial cells. Breast Cancer Res Treat 17:221-230.
18. Fantl WJ, Escobedo JA, Martin GA, Turck CW, del-Rosario M, McCormick F, Willams LT. 1992. Distinct phosphotyrosines in a growth factor receptor bind to specific molecules that mediate different signaling pathways. Cell 69:413-423.
19. Fedi P, Pierce JH, Di Fiore PP, Kraus MH. 1994. Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase Cγ or GTPase-activating protein, distinguishes erbB-3 signaling from that of other erbB/EGFR family members. Mol Cell Biol 14:492-500.
20. Goldman R, Ben Levy R, Peles E, Yarden Y. 1990. Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation. Biochemistry 29:11024-11028.
21. Hammond SL, Ham RG, Stampfer MR. 1984. Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract. Proc Natl Acad Sci USA 81:5435-5439.
22. Hiles ID, Masayuki O, Volinia S, Fry MJ, Gout I, Dhand R, Panayotou G, Ruiz-Larrea F, Thompson A, Tooty NF, Hsuan JJ, Courtneidge SA, Parker PJ, Waterfield MD. 1992. Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit. Cell 70: 419-429.
23. erbB2. Science 256:1205-1210.
24. Hu P, Margolis B, Skolnik Y, Lammers R, Ullrick A, Schlessinger J. 1992. Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors. Mol Cell Biol 12:981-990.
25. Janes PW, Daly RJ, deFazio A, Sutherland RL. 1994. Activation of the ras signalling pathway in human breast cancer cells overexpressing erbB-2. Oncogene 9:3601-3608.
26. Kaplan DR, Whitman M, Schaffhausen B, Pallas DC, White M, Cantley LC, Roberts TM. 1987. Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity. Cell 50:1021-1029.
27. Karunagaran D, Tzahar E, Liu N, Wen D, Yarden Y. 1995. Neu differentiation factor inhibits EGF binding. J Biol Chem 270:9982-9990.
28. Karunagaran D, Tzahar E, Beerli RR, Chen X, Graus-Porta D, Ratzkin BJ, Seger R, Hynes NE, Yarden Y. 1996. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO J 15:254-264.
29. Kim H-H, Sierke SL, Koland JG. 1994. Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB3 gene product. J Biol Chem 269:24747-24755.
30. King CR, Borrello I, Bellot F, Comoglio P, Schlessinger J. 1988. EGF binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3. EMBO J 7:1647-1651.
31. Kita YA, Barff J, Duanzhi W, Luo Y, Wen D, Brankow D, Hu S, Liu N, Prigent SA, Gullick WJ, Nicolson M. 1994. NDF/heregulin stimulates the phosphorylation of Her3/erbB3. FEBS Lett 349:139-143.
32. Kraus MH, Issing W, Miki T, Popescu NC, Aaronson SA. 1989. Isolation and characterization of ERBB3, a third member of the ERBB/ epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc Natl Acad Sci USA 86:9193-9197.
33. Lam K, Carpenter CL, Ruderman NB, Friel JC, Kelley KL. 1994. The phosphatidylinositol 3-kinase serine kinase phosphorylates IRS-1: stimulation by insulin and inhibition by wortmannin. J Biol Chem 269:20648-20652.
34. Lonardo F, Di Marco E, King CR, Pierce JH, Segatto O, Aaronson SA, Di Fiore PP. 1990. The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand. New Biologist 2:992-1003.
35. Marte BM, Graus-Porta D, Jeschke M, Fabbro D, Hynes NE, Taverna D. 1995. NDF/heregulin activates MAP kinase and p70/p85 S6 knase during proliferation or differentiation of mammary epithelial cells. Oncogene 10:167-175.
36. McGlade CJ, Ellis C, Reedijk M, Anderson D, Mbamalu G, Reith AD, Panayotou G, End P, Bernstein A, Kazlauskas A, Waterfield MD, Pawson T. 1992. SH2 domains of the p85α subunit of phosphatidylinositol 3-kinase regulate binding to growth factor receptors. Mol Cell Biol 12:991-997.
37. Merlo GR, Basolo F, Fiore L, Duboc L, Hynes NE. 1995. p53-dependent and p53-independent activation of apoptosis in mammary epithelial cells reveals a survival function of EGF and insulin. J Cell Biol 128:1185-1196.
38. Nakanishi H, Brewer KA, Exton JH. 1993. Activation of the ζ isozyme of protein kinase C by phosphatidylinositol 3,4,5-triphosphate. J Biol Chem 268:13-16.
39. c-src complexes, and PI3-kinase. Cell 65:91-104.
40. Peles E, Ben-Levy R, Or E, Ullrich A, Yarden Y. 1991. Oncogenic forms of the neu/HER2 tyrosine kinase are permanently coupled to phospholipase Cγ. EMBO J 10:2077-2087.
41. Peles E, Lamprecht R, Ben-Levy R, Tzahar E, Yarden Y. 1992. Regulated coupling of the neu receptor to phosphatidylinositol 3′-kinase and its release by oncogenic activation. J Biol Chem 267: 12266-12274.
42. Pinkas-Kramarski R, Soussan L, Waterman H, Levkowitz G, Alroy I, Klapper L, Lavi S, Seger R, Ratzkin BJ, Sela M, Yarden Y. 1996. Diversification of neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J 15:2452-2467.
43. erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci USA 90:1746-1750.
44. erbB4. Nature 366:473-475.
45. erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent mammary carcinoma cells with c-erbB-2 gene amplification. Cell Growth Differ 7:551-561.
46. Ram TG, Kokeny KE, Dilts CA, Ethier SP. 1995. Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin-like growth factor-I in human mammary epithelial cells. J Cell Physiol 163:589-596.
47. erbB-2. Mol Carcinog 15:227-238.
48. Roche S, Koegl M, Courtneige SA. 1994. The phosphatidylinositol 3-kinase a is required for DNA synthesis induced by some, but not all, growth factors. Proc Natl Acad Sci USA 91:9185-9189.
49. Schaefer G, Fitzpatrick VD, Sliwkowski MX. 1998. Gamma-heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175. Oncogene 15:1385-1394.
50. Severinsson L, Ek B, Mellstrom K, Claesson-Welsh L, Heldin C-H. 1990. Deletion of the kinase insert sequence of platelet-derived growth factor β-receptor affects receptor kinase activity and signal transduction. Mol Cell Biol 10:801-809.
51. Shurtleff SA, Downing JR, Rock CO, Hawkins SA, Roussel MF, Sherr CJ. 1990. Structural features of the colony-stimulating factor 1 receptor that affect its association with phosphatidylinositol 3-kinase. EMBO J 9:2415-2421.
52. Siegel PM, Ryan ED, Cardiff RD, Muller WJ. 1999. Elevated expression of activated forms of neu/erbB-2 and erbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer. EMBO J 18:2149-2164.
53. Skolnik EY, Margolis B, Mohammadi M, Lowenstein E, Fischer R, Drepps A, Ullrich A, Schlessinger J. 1991. Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases. Cell 65:83-90.
54. Sliwkowski MX, Schaefer G, Akita RW, Lofgren JA, Fitzpatrick VD, Nuijens A, Fendly BM, Cerione RA, Carraway III KL. 1994. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J Biol Chem 269:14661-14665.
55. Soltoff SP, Carraway III KL, Prigent SA, Gullick WG, Cantley LC. 1994. ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor. Mol Cell Biol 14:3550-3558.
56. Soule HD, Maloney TM, Wolman SR, Peterson WD Jr, Brentz R, McGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC. 1990. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50:6075-6086.
57. Stampfer MR, Hallowes RC, Hackett AJ. 1980. Growth of normal human mammary epithelial cells in culture. In Vitro 16:415-425.
58. Stover DR, Becker M, Liebetanz J, Lydon NB. 1995. Src phosphorylation of the epidermal growth factor receptor at novel sites mediates receptor interaction with src and p85α. J Biol Chem, 270: 15591-15597.
59. Susa M, Keeler M, Varticovski L. 1992. Platelet-derived growth factor activates membrane-associated phosphatidylinositol 3-kinase and mediates its translocation from the cytosol. J Biol Chem 2687: 22951-22956.
60. Tzahar E, Levkowitz G, Karunagaran D, Yi L, Peles E, Lavi S, Chang D, Liu N, Yayon A, Wen D, Yarden Y. 1994. ErbB-3 and erbB-4 function as the respective low and high affinity receptors of all neu differentiation factor/heregulin isoforms. J Biol Chem 269:25226-25233.
61. Tzahar E, Waterman H, Chen X, Levkowitz G, Karunagaran D, Lavi S, Ratzkin BJ, Yarden Y. 1996. A hierarchical network of interreceptor interactions determines signal transduction by neu differentiation factor/neuregulin and epidermal growth factor. Mol Cell Biol 16:5276-5287.
62. Ullrich A, Schlessinger J. 1990. Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212.
63. Varticovski L, Harrison-Findik D, Keeler ML, Susa M. 1994. Role of PI 3-kinase in mitogenesis. Biochim Biophys Acta 1226:1-11.
64. neu protein and EGF receptor modulates EGF receptor function. Cell 61:1339-1347.
65. Wallasch C, Weiβ FU, Niederfellner G, Jalla B, Issing W, Ullrich A. 1995. Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3. EMBO J 14:4267-4275.
66. Wen D, Peles E, Cupples R, Suggs SV, Bacus SS, Luo Y, Trail G, Hu S, Silbiger SM, Levy RB, Koski RA, Lu HS, Yarden Y. 1992. Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobin homology unit. Cell 69:559-572.
67. Whitman M, Kaplan DR, Schaffhausen B, Cantley L, Roberts TM. 1985. Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation. Nature 315: 239-242.
68. Yamamoto K, Lapetina EG, Moxham CP. 1992. Insulin like growth factor-I induces limited association of phosphatidylinositol 3-kinase to its receptor. Endocrinology 130:1490-1498.